ASCO Clinical Practice Guidelines 跳到 Breast Cancer - : Chemotherapy and Targeted Therapy for Women With Human Epidermal Growth Factor Receptor 2–Negative (or unknown) ...
Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Soci 1. J Clin Oncol. 2013 Nov 1;31(31):3997-4013. doi: 10.1200/JCO.2013.50.9984. Epub 2013 Oct 7. Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists ...
R SCREENING Breast Cancer Screening | September 2013 Clinical Practice Guideline Page 4 of 14 Background Follow recommendations from Medical Genetics regarding screening and risk reduction. For eligible women who decline or are unable to attend counseling, follow the
Adjuvant Endocrine Therapy for Women With Hormone Receptor–Positive Breast Cancer: American Society Results This guideline update reflects emerging data on duration of tamoxifen treatment. There have been five studies of tamoxifen treatment beyond 5 years of therapy. The two largest studies with longest reported follow-up show a breast cancer ...
Familial breast cancer | Guidance and guidelines | NICE Familial breast cancer: Classification and care of people at risk of familial breast cancer and management of breast cancer and related risks in people with a family ... This clinical guideline updates and replaces NICE clinical guideline 41 (published in
Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Soci Purpose To update the American Society of Clinical Oncology (ASCO)/College of American Pathologists (CAP) guideline recommendations for human epidermal growth factor receptor 2 (HER2) testing in breast cancer to improve the accuracy of ...
Breast - Cancer Council Australia Find out information about breast cancer, including incidence and mortality, screening, symptoms and diagnosis, causes, and treatment. ... Treatment Treatment depends on the extent of the cancer. For localised breast cancer, the most extensive surgical op
Breast cancer - managing FH - NICE CKS 2013-12-01 Last revised in December 2013 Breast cancer - managing FH - Summary A family history of breast cancer is one of the strongest risk factors for developing breast cancer, increasing with the number of affected relatives. This risk is modified by
Guidelines and Protocols Advisory Committee - Breast Cancer: Management and Follow-up Scope This guideline provides recommendations for management and follow-up of biopsy-proven breast cancer in women aged ≥ 19 years. For diagnostic recommendations, please refer to BCGuidelines.ca - Breast Disease & Cancer: Diagnosis. Refer to Appendix A f
Ann Oncol -- Collected Resources : Clinical Practice Guidelines 2013 Items 1 - 10 of 11 ... Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
